Index Entries

1985 Results
TitleIS Publication Date
SARS-CoV-2 mass vaccination: Urgent questions on vaccine safety that demand answers from international health agencies, regulatory authorities, governments and vaccine developersMay 20, 2021
SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database AnalysisAugust 30, 2021
SARS-COV-2 mRNA Vaccine (BNT162, PF-07302048) — 2.6.4 Summary statement of the pharmacokinetic study
SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levelsSeptember 17, 2020
SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In VitroMarch 21, 2022
SARS-CoV-2 re-infection risk in AustriaFebruary 13, 2021
SARS-CoV-2 RNA reverse-transcribed and integrated into the human genomeDecember 13, 2020
SARS-CoV-2 S1 Protein Persistence in SARS-CoV-2 Negative Post-Vaccination Individuals with Long COVID/ PASC-Like SymptomsJuly 12, 2022
SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 MicrogliaOctober 28, 2021
SARS-CoV-2 spike mRNA vaccine sequences circulate in blood up to 28 days after COVID-19 vaccinationJanuary 17, 2023
SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19April 5, 2023
SARS-CoV-2 spike protein alone may cause lung damageApril 27, 2021
SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic CellsNovember 23, 2021
SARS-CoV-2 Spike Protein and Lung Vascular CellsDecember 30, 2020
SARS-CoV-2 spike protein causes blood coagulation and thrombosis by competitive binding to heparan sulfateOctober 29, 2021
SARS-CoV-2 Spike Protein Disrupts Blood–Brain Barrier Integrity via RhoA ActivationOctober 23, 2021
SARS-CoV-2 Spike Protein Elicits Cell Signaling in Human Host Cells: Implications for Possible Consequences of COVID-19 VaccinesJanuary 11, 2021
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2March 31, 2021
SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapyOctober 13, 2021
SARS-CoV-2 spike protein induces cognitive deficit and anxiety-like behavior in mouse via non-cell autonomous hippocampal neuronal deathMarch 31, 2022
SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier IntegrityJune 11, 2021
SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects
SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegenerationMarch 24, 2021
SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19August 20, 2021
SARS-CoV-2 Spike protein S2 subunit modulates γ-secretase and enhances amyloid-β production in COVID-19 neuropathySeptember 30, 2022
SARS-CoV-2 Spike protein suppresses CTL-mediated killing by inhibiting immune synapse assemblyNovember 15, 2022
SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapiesAugust 2, 2021
SARS-CoV-2 spike S2 subunit inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cellsApril 15, 2024
SARS-CoV-2 Spike Targets USP33-IRF9 Axis via Exosomal miR-148a to Activate Human MicrogliaApril 14, 2021
SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signalingDecember 9, 2022
SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopeniaApril 4, 2022
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million ResidentsApril 20, 2022
SARS-CoV-2 Vaccination and the Multi-Hit Hypothesis of OncogenesisDecember 17, 2023
SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitisApril 21, 2022
SARS-CoV-2 Vaccination-Induced Thrombotic Thrombocytopenia: A Rare but Serious Immunologic ComplicationJuly 18, 2022
SARS-CoV-2 vaccine and increased myocarditis mortality risk: A population based comparative study in JapanDecember 22, 2022
SARS-CoV-2 Vaccine Breakthrough Surveillance and Case Information ResourceOctober 27, 2021
SARS-CoV-2 vaccine protection and deaths among US veterans during 2021November 4, 2021
SARS-CoV-2 variants of concern and variants under investigation in England - Technical briefing 20August 6, 2021
SARS-CoV-2 variants of concern and variants under investigation in England – Technical briefing 23September 17, 2021
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controlsJuly 15, 2020
SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cellsJune 30, 2021
SARS-CoV2 spike protein pathogenicity research collectionDecember 3, 2024
SARS-CoV2 vaccine and viral variant research libraryJanuary 3, 2025
SARS-like WIV1-CoV poised for human emergenceMarch 14, 2016
School children’s mental health during the COVID-19 pandemicJanuary 4, 2024
School in the time of CovidJuly 20, 2022
School Mask Mandates and Student SARS-CoV-2 Infections: Evidence from a Natural Experiment of Neighboring K-12 Districts in North Dakota, USAJanuary 30, 2025
Science Committee hearing: Testimony of Dr. Peter HotezMarch 5, 2020
Science summary: COVID-19 vaccines’ effectiveness and safety exaggerated in clinical trials & observational studies, academics findFebruary 28, 2024